Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways.
Adrenergic beta-2 Receptor Agonists
/ administration & dosage
Aged
Benzoxazines
/ administration & dosage
Bronchi
/ drug effects
Bronchodilator Agents
/ administration & dosage
Drug Combinations
Drug Synergism
Female
Humans
Male
Middle Aged
Muscarinic Antagonists
/ administration & dosage
Muscle, Smooth
/ drug effects
Tiotropium Bromide
/ administration & dosage
Human airways
Olodaterol
Synergy
Tiotropium bromide
Journal
Pulmonary pharmacology & therapeutics
ISSN: 1522-9629
Titre abrégé: Pulm Pharmacol Ther
Pays: England
ID NLM: 9715279
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
30
01
2019
revised:
08
03
2019
accepted:
08
03
2019
pubmed:
17
3
2019
medline:
28
2
2020
entrez:
17
3
2019
Statut:
ppublish
Résumé
Combining a long-acting β
Identifiants
pubmed: 30876907
pii: S1094-5539(19)30036-7
doi: 10.1016/j.pupt.2019.03.004
pii:
doi:
Substances chimiques
Adrenergic beta-2 Receptor Agonists
0
Benzoxazines
0
Bronchodilator Agents
0
Drug Combinations
0
Muscarinic Antagonists
0
tiotropium-olodaterol
0
Tiotropium Bromide
XX112XZP0J
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
39-50Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.